Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-18T19:31:04.561Z Has data issue: false hasContentIssue false

Chapter 18 - Hepatitis B virus infection

from Section III - Hepatitis and immune disorders

Published online by Cambridge University Press:  05 March 2014

By
Mei-Hwei Chang
Edited by
Frederick J. Suchy ,
Ronald J. Sokol  and
William F. Balistreri
Mei-Hwei Chang
Affiliation:
Department of Pediatrics and Hepatitis Research Center, National Taiwan University Hospital, College of Medicine, Taipei, Taiwan
Frederick J. Suchy
Affiliation:
University of Colorado Medical Center
Ronald J. Sokol
Affiliation:
University of Colorado Medical Center
William F. Balistreri
Affiliation:
University of Cincinnati College of Medicine
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Liver Disease in Children , pp. 276 - 294
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ganem, D, Prince, AM. Hepatitis B virus infection natural history and clinical consequences. N Engl J Med 2004;350:1118–1129.CrossRefGoogle ScholarPubMed
Hsu, HY, Chang, MH, Chen, DS, et al. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986;18:301–307.CrossRefGoogle ScholarPubMed
Nassal, M. Hepatitis B viruses: Reverse transcription a different way. Virus Research 2008;134:235–249.CrossRefGoogle ScholarPubMed
Murray, JM, Purcell, R, Wieland, SF. The half life of hepatitis B virions. Hepatology 2006;44:1117–1121.CrossRefGoogle ScholarPubMed
Balistreri, WF. Viral hepatitis. Emerg Clin North Am 1991;9:365–399.Google Scholar
Hoofnagle, JH, DiBisceglie, AM. Serologic diagnosis of acute and chronic viral hepatitis. Semin Liver Dis 1991;11:73–83.CrossRefGoogle ScholarPubMed
Andersson, KL, Raymond, T, Chung, RT. Monitoring during and after antiviral therapy for hepatitis B. Hepatology 2009;49:S166–S173.CrossRefGoogle ScholarPubMed
McQuillan, GM, Coleman, PJ, Kruszon-Moran, D, et al. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999;89:14–18.CrossRefGoogle ScholarPubMed
Custer, B, Sullivan, SD, Hazlet, TK, et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004;38:S158–S168.CrossRefGoogle ScholarPubMed
Feret, E, Larouze, B, Diop, B, et al. Epidemiology of hepatitis B virus infection in the rural community of Tip, Senegal. Am J Epidemiol 1987;125:140–149.CrossRefGoogle ScholarPubMed
Beasley, RP. Rocks along the road to the control of HBV and HCC. Ann Epidemiol 2009;19:231–234.CrossRefGoogle ScholarPubMed
Hsu, HY, Chang, MH, Hsieh, KH, et al. Cellular immune response to hepatitis B core antigen in maternal infant transmission of hepatitis B virus. Hepatology 1992;15:770–776.CrossRefGoogle ScholarPubMed
Lee, SD, Lo, KJ, Tsai, YT, et al. Role of caesarian section in the prevention of mother-to-infant transmission of the hepatitis B virus. Lancet 1988;ii:833–834.CrossRefGoogle Scholar
Tang, JR, Hsu, HY, Lin, HH, et al. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr 1998;133:374–377.CrossRefGoogle ScholarPubMed
Li, XM, Shi, MF, Yang, YB, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004;10:3215–3217.CrossRefGoogle ScholarPubMed
Beasley, RP, Stevens, CE, Shiao, IS, Meng, HC. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet 1975;2:740–741.CrossRefGoogle ScholarPubMed
Gartner, LM, Morton, J, Lawrence, RA, et al. Breastfeeding and the use of human milk. Pediatrics 2005;115:496–506.Google ScholarPubMed
Bhaduri, BR, Mieli-Vergani, G. Fulminant hepatic failure: pediatric aspects. Semin Liver Dis 1996;16:349–355.CrossRefGoogle ScholarPubMed
Chang, MH, Lee, CY, Chen, DS, Hsu, HC, Lai, MY. Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. J Pediatr 1987;111:34–39.CrossRefGoogle ScholarPubMed
Hsu, HY, Chang, MH, Lee, CY, et al. Precore mutant of hepatitis B virus in childhood fulminant hepatitis B: an infrequent association. J Infect Dis 1995;171:776–781.CrossRefGoogle ScholarPubMed
Chang, MH, Hsu, HY, Hsu, HC, et al. The significance of spontaneous HBeAg seroconversion in childhood: with special emphasis on the clearance of HBeAg before three years of age. Hepatology 1995;22:1387–1392.Google Scholar
Chu, CM, Karayiannis, P, Fowler, MJ, et al. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 1985;5:431–434.CrossRefGoogle ScholarPubMed
Bortolotti, F, Cadrobbi, M, Crivellaro, C, et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus in infection in childhood. Gastroenterology 1990;99:805–810.CrossRefGoogle ScholarPubMed
Chang, MH, Sung, JL, Lee, CY, et al. Factors affecting the clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. J Pediatr 1989;115:385–390.CrossRefGoogle ScholarPubMed
Wu, JF, Su, YR, Chen, CH, et al. Predictive effect of serial serum alanine aminotransferase levels on spontaneous HBeAg seroconversion in chronic genotype B and C HBV-infected children. J Pediatr Gastroenterol Nutr 2012;54:97–100.CrossRefGoogle Scholar
Bortolotti, F, Guido, M, Bartolacci, S, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 2006;43:556–562.CrossRefGoogle Scholar
Bortolotti, F, Wirth, S, Crivellaro, C, et al. Long-term persistence of hepatitis B virus DNA in the serum of children with chronic hepatitis B after hepatitis B e antigen to antibody seroconversion. J Pediatr Gastroenterol Nutr 1996;22:270–274.CrossRefGoogle ScholarPubMed
Chu, CM, Liaw, YF. Spontaneous relapse of hepatitis in inactive HBsAg carriers. Hep Intl 2007;1:311–315.CrossRefGoogle ScholarPubMed
Liaw, YF. Natural historyof chronic hepatitis B virus infection and long-term outcome under treatment. Liver International 2009;29(s1):100–107.CrossRefGoogle Scholar
Ni, YH, Chang, MH, Chen, PJ, et al. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. Gastroenterology 2007;132:2340–2345.CrossRefGoogle ScholarPubMed
Hsu, HY, Chang, MH, Lee, CY, et al. Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology 1992;15;382–386.CrossRefGoogle ScholarPubMed
Chu, CM, Liaw, YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology 2007;45:1187–1192.CrossRefGoogle ScholarPubMed
Chang, MH, Hwang, LY, Hsu, HC, Lee, CY, Beasley, RP. Prospective study of asymptomatic HBsAg carrier children infected in the perinatal period: clinical and liver histologic studies. Hepatology 1988;8:374–377.CrossRefGoogle ScholarPubMed
Hsu, HC, Lin, YH, Chang, MH, et al. Pathology of chronic hepatitis B virus infection in children: with special reference to the intrahepatic expression of hepatitis B virus antigens. Hepatology 1988;8:378–382.CrossRefGoogle ScholarPubMed
Tseng, YR, Wu, JF, Ni, YH, et al. Long-term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection. Liver Int 2011;31:1373–1380.CrossRefGoogle ScholarPubMed
Wu, JF, Wu, TC, Chen, CH, et al. Serum levels of interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversiston. Gastroenterology 2010;138:165–172.CrossRefGoogle Scholar
Lin, CL, Kao, JH. The clinical implications of hepatitis B virus genotype: Recent advances. J Gastroenterol Hepatol 2011;26(Suppl 1):123–130.CrossRefGoogle ScholarPubMed
Ni, YH, Chang, MH, Wang, KJ, et al. Clinical relevance of hepatitis B virus genotype in children with chronic hepatitis B and hepatocellular carcinoma. Gastroenterology 2004;127:1733–1738.CrossRefGoogle ScholarPubMed
Chen, CJ, Yang, HI, Iloeje, UH, for the REVEAL-HBV Study Group. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 2009;49(5 Suppl):S72–S84.CrossRefGoogle ScholarPubMed
Chang, MH, Hsu, HY, Ni, YH, et al. Precore stop codon mutant in chronic hepatitis B virus infection in children: Its relation to hepatitis B e seroconversion and natural hepatitis B surface antigen. J Hepatol 1998;28:915–922.CrossRefGoogle Scholar
Ni, YH, Chang, MH, Hsu, HY, Tsuei, DJ. Longitudinal study on mutation profiles of core promoter and precore regions of the hepatitis B virus genome in children. Pediatr Res 2004;56:396–399.CrossRefGoogle ScholarPubMed
Ni, YH, Chang, MH, Hsu, HY, Tsuei, DJ. Different hepatitis B virus core gene mutations in children with chronic infection versus hepatocellular carcinoma. Gut 2003;52:122–125.CrossRefGoogle Scholar
Jonas, MM, Block, JM, Haber, BA, et al. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology 2010;52:2192–2205.CrossRefGoogle ScholarPubMed
Torre, D, Tambini, R. Interferon-α therapy for chronic hepatitis B in children: a meta-analysis. Clin Infect Dis 1996;23:131–137.CrossRefGoogle ScholarPubMed
Sokal, EM, Conjeevaram, HS, Roberts, EA, et al. Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology 1998;114:988–995.CrossRefGoogle ScholarPubMed
Bortolotti, F, Jara, P, Barbera, C, et al. Long term effect of alpha interferon in children with chronic hepatitis B. Gut 2000;46:715–718.CrossRefGoogle ScholarPubMed
Hsu, HY, Tsai, HY, Wu, TC, et al. Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan. Liver Int 2008;28:1288–1297.CrossRefGoogle Scholar
Schwarz, KB, Gonzalez-Peralta, RP, Murray, KF, et al. The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. Gastroenterology 2011;140:450–458.CrossRefGoogle ScholarPubMed
Jonas, M, Kelly, DA, Mizerski, J, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002;346:1706–1713.CrossRefGoogle ScholarPubMed
Sokal, EM, Kelly, DA, Badia, IB, et al. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology 2006;43:225–232.CrossRefGoogle ScholarPubMed
Jonas, MM, Kelly, D, Pollack, H, et al. Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. Hepatology 2008;47:1863–1871.CrossRefGoogle ScholarPubMed
Chang, TT, Gish, RG, de Man, R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006;354:1001–1010.CrossRefGoogle ScholarPubMed
Lai, CL, Shouval, D, Lok, AS, et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2006;354:1011–1020.CrossRefGoogle ScholarPubMed
Tenney, DJ, Rose, RE, Baldick, CJ, et al. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside- naïve patients is rare through 5 years of therapy. Hepatology 2009;49:1503–14.CrossRefGoogle Scholar
Lai, CL, Gane, E, Liaw, YF, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med 2007;357:2576–2588.CrossRefGoogle ScholarPubMed
Seto, WK, Lai, CL, Fung, J, et al. Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome. J Hepatol 2011;55:522–528.CrossRefGoogle ScholarPubMed
Marcellin, P, Heathcote, EJ, Buti, M, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 2008;359:2442–2455.CrossRefGoogle ScholarPubMed
Heathcote, EJ, Marcellin, P, Buti, M, et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology 2011;140:132–143.CrossRefGoogle ScholarPubMed
D’Antiga, L, Aw, M, Atkins, M, et al. Combined lamivudine/interferon-alpha treatment in “immunotolerant” children perinatally infected with hepatitis B: a pilot study. J Pediatr 2006;148:228–233.CrossRefGoogle ScholarPubMed
Chen, HL, Lin, LH, Hu, FC, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 2012;142:773–781.CrossRefGoogle ScholarPubMed
Chen, DS, Hsu, NH, Sung, JL, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987;257:2597–2603.CrossRefGoogle ScholarPubMed
Bonanni, P, Crovari, P. Success stories in the implementation of universal hepatitis B vaccination: an update on Italy. Vaccine 1998;16(Suppl):S38–S42.CrossRefGoogle ScholarPubMed
Wasley, A, Grytdal, S, Gallagher, K; Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis: United States, 2006. MMWR Surveill Summ 2008;57:1–24.Google ScholarPubMed
Ni, YH, Huang, LM, Chang, MH, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007;132:1287–1293.CrossRefGoogle ScholarPubMed
Viviani, S, Jack, A, Hall, AJ, et al. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine 1999;17:2946–2950.CrossRefGoogle ScholarPubMed
Kao, JH, Hsu, HM, Shaw, WY, Chang, MH, Chen, DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 2001;139:349–352.CrossRefGoogle ScholarPubMed
Chang, MH, Chen, CJ, Lai, MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336:1855–1859.CrossRefGoogle ScholarPubMed
Chang, MH, You, SL, Chen, CJ, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009;101:1348–1355.CrossRefGoogle ScholarPubMed
Su, WJ, Ho, MC, Ni, YH, et al. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. J Pediatr Gastroenterol Nutr 2009;48:203–208.CrossRefGoogle ScholarPubMed
Hsu, HY, Chang, MH, Ni, YH, et al. No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J Infect Dis 2010;201:1192–1200.CrossRefGoogle Scholar
Centers for Disease Control and Prevention. Hepatitis B Slide Set. Atlanta, GA: Centers for Disease Control and Prevention, 2006 (, accessed January 26, 2006).Google Scholar
Rizzetto, M, Canese, MG, Arico, S, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977;18:997–1003.CrossRefGoogle ScholarPubMed
Fattowich, G, Giustina, G, Christensen, E, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. Gut 2000;46:420–426.CrossRefGoogle Scholar
Bortolotti, F, Di Marco, V, Vajro, P, et al. Long-term evolution of chronic delta hepatitis in children. J Pediatr 1993;122:736–738.CrossRefGoogle ScholarPubMed
Mele, A, Mariano, A, Tosti, ME, et al. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti–hepatitis B vaccination campaign. Clin Infect Dis 2007;44:e17–e24.CrossRefGoogle ScholarPubMed
Di Marco, V, Giacchino, R, Timitilli, A, et al. Long-term interferon-alpha treatment of children with chronic hepatitis delta: a multicentre study. J Viral Hepat 1996;3:123–128.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×